The research began with a systematic bioprospecting exercise. Fifteen species were selected from the Qinling Mountains on the basis of local abundance and regional representativeness, ranging from familiar solanaceous herbs to Allium species, legumes and Asteraceae shrubs. Plant material was rinsed, air-dried, oven-dried at 45 degrees Celsius, ground and sieved before being extracted with ninety-five percent ethanol at a solid-to-liquid ratio of one to four for forty-eight hours, with the process repeated twice on the residue. The combined filtrates were concentrated on a rotary evaporator to yield crude extracts, which were then dissolved into stock solutions and diluted to test concentrations. This simple but rigorous pipeline allowed the team to compare all fifteen species on an equal footing before committing resources to any single candidate.

Laboratory bioassays were built around three complementary measures of pest suppression: direct larvicidal toxicity, antifeedant activity and oviposition repellency. For the toxicity screen, five-centimeter cabbage leaf discs were dipped in each extract at fifty milligrams per milliliter, air-dried, and offered to twenty starved third-instar larvae per dish, with mortality scored at twenty-four, forty-eight and seventy-two hours. The results revealed striking interspecific differences and a clear time-dependent pattern. At twenty-four hours, Atropa belladonna extract already led the field with a corrected mortality of 58.87 percent, well ahead of Asparagus dauricus, Allium ochotense, Tupistra wattii and Blumea riparia var. megacephala. By seventy-two hours, A. belladonna had reached 83.11 percent, the only extract to break the eighty percent barrier, while B. riparia var. megacephala climbed to 73.53 percent. Ten of the fifteen extracts never exceeded fifty percent mortality, and Solanum nigrum was barely distinguishable from the ethanol control.

The behavioral assays told an equally compelling story. In the leaf-disc antifeedant test, smaller treated and untreated discs were offered to larvae, and consumed leaf area was measured after forty-eight hours. B. riparia var. megacephala and A. belladonna again dominated, with antifeedant rates of 87.45 and 89.46 percent respectively, meaning larvae ate only a small fraction of the foliage consumed by untreated controls. Extracts of A. ochotense, A. dauricus and Bauhinia championi also held rates above eighty percent, while several others faded over time. The oviposition assay extended the effect beyond feeding: potted Chinese cabbage plants sprayed with extract and caged with twenty adult moths received far fewer eggs than ethanol-treated controls. B. riparia var. megacephala reduced egg-laying by 82.14 percent, leaving just 1.25 eggs per plant, and A. belladonna achieved 78.57 percent repellency. Together, the data suggested these two plants attack the moth at multiple points in its life cycle.

With two standouts identified, the researchers asked whether combining them would improve performance. Eleven treatments were prepared in a volumetric series spanning pure A. belladonna to pure B. riparia var. megacephala, and the median lethal concentration of each was determined by probit analysis. Alone, A. belladonna showed an LC50 of 76.69 milligrams per milliliter against the more toxic B. riparia var. megacephala at 95.53. The critical result came from the eight-to-two mixture, which lowered the LC50 to 65.76 milligrams per milliliter, better than either single extract. Using the co-toxicity coefficient framework of Chinese pesticide standards, where values at or above 120 indicate synergism, at or below 80 indicate antagonism and values between indicate additivity, the eight-to-two blend scored 110. The authors are careful to call this an additive effect rather than true synergism, but the absence of any antagonistic combination, even at ratios where the weaker extract dominated, is a meaningful signal that the two extracts are chemically compatible partners.

Why might these particular plants be so potent? The team draws on phytochemical literature to build plausible, though deliberately tentative, mechanistic hypotheses. Atropa belladonna, the infamous deadly nightshade, is rich in tropane alkaloids including hyoscyamine, scopolamine and norhyoscyamine, compounds known to interact with insect muscarinic acetylcholine receptors and thereby disrupt cholinergic signaling and neural transmission. Blumea species, by contrast, produce sesquiterpene-rich volatile oils and diverse flavonoids, compound classes associated elsewhere with feeding deterrence, digestive enzyme inhibition and interference with detoxification enzymes. Allium ochotense owes its activity, if the pattern holds, to sulfur-containing compounds and steroidal saponins that can induce oxidative stress and permeate cell membranes. Because the study did not perform chemical profiling of the extracts, these explanations remain literature-supported hypotheses rather than demonstrated mechanisms, and the authors are explicit about that limitation.

Translating laboratory promise into a sprayable product required formulation chemistry. The combined eight-to-two extract was tested against four organic solvents, and ethanol was chosen over dimethyl sulfoxide and methanol for its lower toxicity and favorable stability, while petroleum ether failed solubility requirements outright. Four surfactant systems were then screened. Formulations containing pesticide emulsifier 500# combined with NP-2 remained homogeneous and transparent through high-temperature storage at 54 degrees Celsius for fourteen days, low-temperature storage near freezing for a week, and dilution testing, whereas OP-10 and emulsifier 601# showed precipitation under stress. Concentration optimization settled on five percent emulsifier 500# and eight percent NP-2. The final emulsifiable concentrate contained ten percent active ingredients, seventy-seven percent ethanol and the two emulsifiers, and it passed the physicochemical stability benchmarks, though the authors caution that these accelerated tests are not a substitute for a full shelf-life evaluation.

The decisive test came in the field. In a randomized complete block trial on cruciferous vegetables in Jingyang County, the ten percent botanical formulation diluted one hundred times was compared with emamectin benzoate, a widely used macrocyclic lactone insecticide, and a water-sprayed control across twelve plots. The pattern of action differed sharply between treatments. Emamectin benzoate, which paralyzes insects by acting on glutamate-gated chloride channels, showed faster knockdown in the first day. The botanical spray started slowly, delivering only 10.86 percent control at day one, but its performance climbed steadily as its toxic, antifeedant and reproductive effects accumulated. By seven days after application, the botanical formulation had achieved 58.35 percent control, statistically indistinguishable from the 60.58 percent achieved by emamectin benzoate. Meanwhile, the untreated plots saw larval populations surge by more than thirty percent, underscoring how much pressure the pest exerts when left alone.

The researchers and outside observers alike stress that 58.35 percent is moderate efficacy, not commercial-grade knockout, and the trial covered a single site and one growing season. But the trajectory is what makes the study noteworthy: a crude plant combination, formulated without synthetic active ingredients, matching a leading chemical insecticide within a week of application suggests genuine development potential rather than a laboratory curiosity. The authors outline the road ahead with commendable candor. Chemical profiling by LC-MS or GC-MS and bioassay-guided fractionation are needed to identify the actual active constituents. Safety evaluation is not optional, because natural origin does not equal safety: A. belladonna’s tropane alkaloids can pose risks to humans, livestock and beneficial insects at sufficient exposure, so mammalian toxicity, non-target effects, residues and environmental fate all require dedicated study. Resistance management potential, multi-location trials and dosage optimization round out the agenda. If those hurdles are cleared, the Qinling Mountains may have supplied an unlikely gift to cabbage growers worldwide: a plant-based spray that the diamondback moth has not yet learned to beat.

Subject of Research: Botanical insecticide screening and field evaluation against the diamondback moth Plutella xylostella

Article Title: Bioactivity screening of plant ethanol extracts against Plutella xylostella and field evaluation of an optimized botanical combination formulation

Article References: Bioactivity screening of plant ethanol extracts against Plutella xylostella and field evaluation of an optimized botanical combination formulation. (n.d.). https://doi.org/10.3389/abp.2026.16918

Image Credits: AI Generated

DOI: 10.3389/abp.2026.16918

Keywords: Plutella xylostella, diamondback moth, botanical insecticide, Atropa belladonna, Blumea riparia, plant extracts, antifeedant activity, insecticide resistance, emulsifiable concentrate, integrated pest management, field trial, cruciferous vegetables

The research team began with a deceptively simple question: which parts of the turnip actually matter for metabolism? Rather than testing a crude extract and stopping there, the investigators employed an activity-guided purification strategy. They ground ten kilograms of dried turnip root, extracted it with ethanol, and then partitioned the resulting material into fractions of increasing chemical refinement. Each fraction was tested in a laboratory model of insulin resistance: HepG2 liver cells bathed in high glucose and palmitic acid, a fatty acid that mimics the lipid overload seen in obesity and diabetes. The researchers measured how much glucose the cells could absorb, a direct readout of insulin sensitivity, and systematically eliminated fractions that showed no activity or toxicity.

The purification funnel narrowed dramatically. Of the two major fractions produced by liquid-liquid partitioning, the n-butanol fraction outperformed the water fraction at promoting glucose uptake. Silica gel chromatography then split this fraction into five subfractions, one of which, designated T-2D, stood out clearly. A second round of reversed-phase chromatography generated four refined subfractions, and the winner was unambiguous: T-3B drove glucose uptake in insulin-resistant hepatocytes to the highest levels observed in the entire screening campaign, reaching nearly 6.9 millimolar under the assay conditions, all without harming cell viability. This stepwise approach, the authors argue, addresses a persistent weakness in natural product research, where crude mixtures and single isolated compounds are often studied in isolation, leaving the interactions among constituents undefined.

With the active fraction in hand, the team moved to animal testing. They used db/db mice, a classic spontaneous model of type 2 diabetes in which animals carry a mutation that renders them obese, insulin resistant, and dyslipidemic. Mice with fasting blood glucose above 11.1 millimolar were randomized into groups receiving either a low dose of T-3B, a high dose, the anti-diabetic drug rosiglitazone as a positive control, or vehicle alone. Treatment was delivered by daily oral gavage for eight consecutive weeks, with body weight, food intake, and fasting glucose tracked weekly throughout.

The metabolic improvements were substantial and, in several respects, dose-dependent. High-dose T-3B lowered fasting blood glucose significantly as early as the second week of treatment, while the low dose produced significant effects by week three. Oral glucose tolerance tests performed after eight weeks showed that treated mice cleared a glucose load far more efficiently than untreated diabetic controls, with the high-dose group’s area under the glucose curve rivaling that of the rosiglitazone group. Insulin tolerance tests confirmed that the treated animals had genuinely recovered sensitivity to the hormone, not merely altered some downstream glucose metric. Body weight and food intake also declined moderately in treated mice, beginning around the sixth week of intervention.

Blood chemistry added another layer of benefit. Circulating levels of glucagon-like peptide-1, or GLP-1, an incretin hormone secreted by intestinal cells that promotes insulin release and satiety, were markedly depressed in the untreated diabetic mice but substantially restored by T-3B treatment. The fraction also corrected the characteristic diabetic lipid profile: plasma triglycerides, total cholesterol, and low-density lipoprotein all fell at the high dose, while high-density lipoprotein rose at both doses tested. Because elevated triglycerides and LDL cholesterol contribute to atherosclerotic risk in diabetic patients, the authors note that this dual glucose-and-lipid effect is exactly the profile sought in next-generation metabolic therapies, and one that many existing drugs only partially achieve.

The liver emerged as the fraction’s primary target organ. Histological staining revealed that untreated db/db mice livers were riddled with fat droplets, with ballooned hepatocytes and disordered tissue architecture, hallmarks of non-alcoholic fatty liver disease. T-3B treatment visibly reversed this steatosis, and biochemical assays confirmed reduced hepatic triglyceride content. Intriguingly, hepatic glycogen, the storage form of glucose, increased significantly in treated mice, while skeletal muscle glycogen remained unchanged, sharpening the picture of a liver-specific mechanism. The researchers propose that this matters because hepatic insulin resistance is an early and central driver of type 2 diabetes: when the liver stops responding to insulin, it churns out glucose uncontrollably while simultaneously importing fatty acids that worsen fat accumulation, creating a self-reinforcing vicious cycle between lipid deposition and metabolic dysfunction.

Molecular and genomic analyses converged on two well-known signaling hubs. Western blotting showed that diabetic mouse livers had blunted phosphorylation of the insulin receptor beta, insulin receptor substrate 1, AKT, and AMPK alpha, the canonical cascade through which insulin instructs the liver to store glucose and cease glucose production. Eight weeks of T-3B treatment rescued these phosphorylation defects in a dose-dependent manner, and parallel experiments in insulin-resistant HepG2 cells reproduced the effect within twenty-four hours. RNA sequencing of liver tissue reinforced the story at the transcriptomic level: more than 1,600 genes changed expression after treatment, with downregulated genes enriched in inflammatory pathways such as NF-kappaB and TNF signaling, oxidative stress responses, and cellular senescence, while upregulated genes clustered in fatty acid oxidation, the PPAR pathway, glycogen biosynthesis, and AMPK signaling itself.

Chemical fingerprinting of T-3B by high-performance liquid chromatography coupled with mass spectrometry and nuclear magnetic resonance identified six monomeric constituents: trans-4-hydroxycinnamic acid, chrysin, ferulic acid, trans-ferulic acid, 4-hydroxy-3,5-dimethoxycinnamic acid, and apigenin. When each was tested individually in insulin-resistant liver cells at twenty micromolar, chrysin and apigenin proved the strongest promoters of glucose uptake, with chrysin the single most potent compound despite not being the most abundant. Combining chrysin and apigenin produced an enhanced effect beyond simple addition, which the authors attribute to their shared flavone backbone and complementary regulatory pathways. Chrysin alone also reduced triglyceride and cholesterol accumulation in fat-injured liver cells, lowered markers of cellular damage, boosted the antioxidant enzyme superoxide dismutase, and reduced malondialdehyde, a marker of oxidative injury.

The authors are careful to flag the limits of their work. The reduced food intake observed in treated mice could partly confound the metabolic benefits, and the team acknowledges that pair-fed control groups would be needed to fully disentangle direct drug effects from dietary restriction. The signaling findings, while consistent, remain correlative without inhibitor or gene-knockdown experiments, the transcriptomic results await validation by quantitative PCR, and the absolute quantities and purity of the individual monomers were not fully quantified. The mechanism behind the restored GLP-1 secretion, whether direct stimulation of intestinal cells, gut signaling, or microbiome remodeling, also remains speculative. Still, the study delivers something the field has lacked: a defined, purified turnip fraction with a mapped component-pathway-phenotype network connecting specific flavones to insulin and energy-sensing signaling in the liver. As diabetes prevalence in China now exceeds twelve percent, well above the global average, and drug side effects push patients toward dietary alternatives, the prospect that a common vegetable harbors multi-target metabolic activity is a finding worth watching closely.

Subject of Research: Bioactive turnip compounds as potential treatments for type 2 diabetes and hepatic insulin resistance

Article Title: Bioactive components from Turnip improve liver and systemic metabolic homeostasis in mice with T2DM

Article References: Ling, Z., Jin, L., Xu, W., Sun, M., Sun, J., Zhou, Z., Liu, Q., Wang, Y., Liu, J., Wu, J., Khattab, O. M., Fu, H., Shou, Q., & Han, J. (2026). Bioactive components from Turnip improve liver and systemic metabolic homeostasis in mice with T2DM. Journal of Agriculture and Food Research, 31, Article 103344. https://doi.org/10.1016/j.jafr.2026.103344

Image Credits: AI Generated

DOI: Not provided

Keywords: turnip, type 2 diabetes, chrysin, apigenin, insulin resistance, liver metabolism, db/db mice, AMPK, PI3K-AKT, flavonoids, GLP-1, fatty liver disease